Clinical Trial Update: Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for apixaban in routine management of upper extremity deep venous thrombosis; study status terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Upper Extremity Deep Venous Thrombosis

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Deep Venous Thrombosis, Upper Extremity Deep Venous Thrombosis | Phase 4 | Status: TERMINATED